Prospective Research Innovations Inc

The trials here

What the 11 trials at this site are about, from their registry records.

Conditions

• Obesity4 trials
• Depression2 trials
• Osteoarthritis2 trials
• Type 2 diabetes2 trials
• Asthma1 trial
• COPD1 trial
• Insomnia1 trial
• Ulcerative colitis1 trial

Phase

• Phase 25 trials
• Phase 35 trials
• Phase 2/31 trial

Status

• Completed5 trials
• Active, not recruiting2 trials
• Recruiting2 trials
• Not yet recruiting1 trial
• Terminated1 trial

Lead sponsor

• Hoffmann-La Roche3 trials
• Janssen Research & Development, LLC2 trials
• Uniquity One (UNI)2 trials
• Carmot Therapeutics, Inc.1 trial
• InDex Pharmaceuticals1 trial
• and 2 more

Running trials

• Recruiting

  A Study to Learn About Study Medicine Called Berobenatide in Adults With Knee Pain and Overweight or Obesity (VESPER-OA 1)

  NCT07919678· Phase 3· Pfizer· Source

• Recruiting

  A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

  NCT07351058· Phase 3· Hoffmann-La Roche· Source

• Recruiting

  A Study to Compare Different Doses of Tifeglipron (RO7795081) With Placebo or Semaglutide in People With Type 2 Diabetes

  NCT07112872· Phase 2· Hoffmann-La Roche· Source

• Active, not recruiting

  A Study to Evaluate Solrikitug in Participants With COPD (ZION)

  NCT06496620· Phase 2· Uniquity One (UNI)· Source

• Active, not recruiting

  Treatment Effects of Subcutaneous Injections of Pentosan Polysulfate Sodium vs Placebo in Participants With Knee OA Pain

  NCT04809376· Phase 2/3· Paradigm Biopharmaceuticals USA (INC)· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Obesity2 recruiting
• Type 2 diabetes2 recruiting
• Osteoarthritis1 recruiting

Closed trials

• Completed

  A Study Evaluating the Effect of Daily Oral Tifeglipron (RO7795081) in Participants With Obesity or Overweight With at Least One Weight-Related Comorbidity

  NCT07081958· Phase 2· Hoffmann-La Roche· Source

• Completed

  A Study of Enicepatide (CT-388) in Participants With Obesity or Overweight With at Least One Weight-Related Comorbidity

  NCT06525935· Phase 2· Carmot Therapeutics, Inc.· Source

• Completed

  A Study to Evaluate Solriktug in Adult Participants With Asthma

  NCT06496607· Phase 2· Uniquity One (UNI)· Source

• Recruiting

  Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms

  NCT06559306· Phase 3· Janssen Research & Development, LLC· Source

• Completed

  A Study of Aticaprant 10 Milligrams (mg) as Adjunctive Therapy in Adult Participants With MDD With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy

  NCT05550532· Phase 3· Janssen Research & Development, LLC· Source

• Terminated

  The Efficacy and Safety of Cobitolimod in Participants With Moderate to Severe Active Left-Sided Ulcerative Colitis

  NCT04985968· Phase 3· InDex Pharmaceuticals· Source